An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy.
Klempner MS, Noring R, Mier JW, Atkins MB. An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med. 1990 Apr 05; 322(14):959-65.